CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
2.265
-0.025 (-1.10%)
At close: Apr 28, 2026, 4:00 PM EDT
2.260
-0.005 (-0.21%)
Pre-market: Apr 29, 2026, 6:04 AM EDT
CNS Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 2 | 3 | 7 | 7 | 3 | 20 | |
| Market Cap Growth | -53.42% | -52.95% | 4.40% | 109.26% | -83.83% | -51.07% | |
| Enterprise Value | -5 | -7 | -0 | 6 | -4 | 11 | |
| Last Close Price | 2.26 | 5.25 | 72.24 | 38100.04 | 72000.07 | 632166.32 | |
| PB Ratio | 0.32 | 0.72 | 1.12 | -1.50 | 0.39 | 3.18 | |
| P/TBV Ratio | 0.41 | 0.72 | 1.12 | - | 0.39 | 3.18 | |
| Debt / Equity Ratio | 0.07 | 0.07 | 0.05 | -0.07 | 0.05 | 0.06 | |
| Net Debt / Equity Ratio | -1.52 | -1.52 | -0.99 | 0.06 | -1.19 | -0.75 | |
| Net Debt / EBITDA Ratio | 0.43 | 0.43 | 0.41 | 0.01 | 0.63 | 0.32 | |
| Net Debt / FCF Ratio | 0.50 | 0.50 | 0.36 | 0.02 | 0.91 | 0.34 | |
| Quick Ratio | 1.76 | 1.76 | 2.91 | 0.09 | 2.04 | 1.93 | |
| Current Ratio | 1.98 | 1.98 | 3.43 | 0.26 | 2.55 | 2.88 | |
| Return on Equity (ROE) | -296.30% | -296.30% | -1703.39% | -1018.78% | -213.68% | -144.15% | |
| Return on Assets (ROA) | -115.35% | -115.35% | -179.08% | -159.83% | -87.50% | -73.58% | |
| Return on Capital Employed (ROCE) | -353.50% | -353.50% | -241.30% | 425.60% | -187.70% | -235.00% | |
| Earnings Yield | -862.53% | -486.73% | -214.67% | -284.36% | -482.14% | -73.97% | |
| FCF Yield | -752.54% | -424.66% | -247.31% | -213.35% | -333.40% | -69.11% | |
| Buyback Yield / Dilution | -1293.23% | -1293.23% | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.